Canaccord Genuity Group Boosts Anpario (LON:ANP) Price Target to GBX 500

Anpario (LON:ANP) had its price target raised by equities researchers at Canaccord Genuity Group from GBX 380 ($4.65) to GBX 500 ($6.12) in a research note issued to investors on Tuesday, MarketBeat reports. The brokerage currently has a “buy” rating on the stock. Canaccord Genuity Group’s price target indicates a potential upside of 13.94% from the stock’s current price.

Separately, Canaccord Genuity Group upped their price target on Anpario from GBX 340 ($4.16) to GBX 370 ($4.53) and gave the stock a “buy” rating in a research note on Wednesday, September 18th.

Anpario Stock Performance

Shares of ANP opened at GBX 438.83 ($5.37) on Tuesday. The company has a current ratio of 6.15, a quick ratio of 5.16 and a debt-to-equity ratio of 0.21. The firm has a market cap of £74.21 million, a PE ratio of 2,437.92 and a beta of 0.58. Anpario has a 12-month low of GBX 220 ($2.69) and a 12-month high of GBX 454.90 ($5.57). The company’s 50 day simple moving average is GBX 362.62 and its 200-day simple moving average is GBX 322.22.

Insider Activity at Anpario

In related news, insider Karen Prior sold 14,000 shares of Anpario stock in a transaction on Friday, December 13th. The stock was sold at an average price of GBX 380 ($4.65), for a total transaction of £53,200 ($65,116.28). Company insiders own 30.51% of the company’s stock.

Anpario Company Profile

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.